Otherside Farms

JANUARY 25, 2019

Norman Smith: “Since I am the only successful patient in the clinical trial, to take away something that’s been part of a successful regimen does not make any sense” In September 2010, Smith became eligible for a liver transplant, but after testing positive for marijuana in February he was removed from the transplant list.

Patients 76

Patients Clinical Trials Marijuana Policy 76

The Cannigma

MAY 19, 2021

Japan has some of the harshest drug policies on Earth, including for cannabis — and is one of the worst places on Earth to get arrested on marijuana possession charges. Japan does not have a medical cannabis program and does not allow the use of cannabis for patients seeking to treat a medical condition.

Law 137

Law Legalization Clinical Trials CBD 137

NORML

JANUARY 4, 2019

Steve Cohen (D-TN) and Don Young (R-AK) re-introduced the Compassionate Access, Research Expansion and Respect States (CARERS) Act, which protects those engaged in state-lawful medical marijuana programs from federal prosecution. Click here to email your member of Congress and urge them to join the Cannabis Caucus. Pennsylvania.

Legislation 126

Legislation Clinical Trials Research and Development Access 126

Cannabis Law Report

JANUARY 12, 2022

Today, Maya (Maya PBC) and the National Psychedelics Association (NPA) announced their partnership in support of the implementation of Oregon’s Measure 109, the first state-approved policy to allow the regulated use of psilocybin products in a facilitated setting.

Research and Development 52

Research and Development Therapy Safety Clinical Trials 52

Cannabis Law Report

JULY 29, 2021

Tetra Bio-Pharma ( TSX: TBP ) ( OTCQB: TBPMF ) ( FRA:JAM1 ) is a leader in cannabinoid-derived drug discovery and development with a FDA and a Health Canada cleared clinical program aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. For more information visit: www.tetrabiopharma.com.

Research and Development 105

Research and Development Clinical Trials Events Cannabinoids 105

Cannabis Law Report

JUNE 19, 2022

The new center is designed to formalize a network of experts across the university based in a range of academic departments as well as existing centers focused on drug policy and substance misuse prevention and recovery. Alan Davis. Jason Slot. Our capacity to reach so many makes this commitment essential.”.

Education 52

Education Research and Development Therapy Clinical Trials 52

Cannabis Law Report

NOVEMBER 19, 2021

It has been designated a Breakthrough Therapy by the FDA and the results of our pivotal Phase 3 clinical trial were published in Nature Medicine or profiled on the front page of The New York Times. Experience in interpretation of regulations, guidelines, policy statements.

Research and Development 52

Research and Development Clinical Trials Therapy Pharmaceutical 52

MMJ Recs

DECEMBER 22, 2023

The STATES Act, for example, represents a step toward allowing states to determine their cannabis policies without federal interference. Peer-reviewed studies, clinical trials, and meta-analyses have played a crucial role in dispelling myths and misconceptions surrounding medical marijuana.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

SpeedWeed

MARCH 5, 2021

Having spent more than 25 years studying cannabis policy and scheduling, I take issue with this interpretation. By contrast, state and local governments are the primary regulators with respect to the creation and enforcement of policies governing to production, use, and sale of alcohol and tobacco. Authors Tracy Gallegos and Neville M.

Business 52

Business Policy Clinical Trials Research and Development 52

Cannabis Law Report

MAY 29, 2022

Clinical Trials and Human Subject Protections. Before the drug approval process even begins, sponsors must initiate clinical investigations by first filing an Investigational New Drug Application (IND) with FDA. FDA’s approval of an IND will also require sufficient evidence that the trial will be safe for human subjects.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

NOVEMBER 15, 2021

CRO orders typically provide a means to evaluate LinearDNA within a customer’s preclinical development program. Hurry, 917-733-5573, sanjay.hurry@adnas.com Program Manager: Brian Viscount, 631-240-8877, brian.viscount@adnas.com Web: www.adnas.com Twitter: @APDN. News release. FDA website. January 15, 2019. 2021 Aug 26;23:119-127.

Research and Development 52

Research and Development Therapy Clinical Trials Supply Chain 52

Cannabis Law Report

OCTOBER 17, 2019

(Tree of Knowledge) (CSE:TOKI) (OTC:TOKIF) expands global medical marijuana and CBD research in partnership with the Caribbean Institute of Pharmacy Policy (CIPPPAR) in Jamaica. Tree of Knowledge will be introducing chronic pain management protocols and research into the Caribbean market.

Clinical Trials 40

Clinical Trials Research and Development Chronic Pain CBD 40

Cannabis Law Report

MARCH 29, 2022

Steven will guide the JEDI Council, a cross-functional team of employees across MAPS and MAPS PBC that guides internal policies and the Health Equity initiative. Dawn remains a faculty member at Penn directing the QA course of study for the ITMAT Masters program. Debra (Deb) De Angelo, Ph.D. , Theresa Gorenc, M.P.H. ,

Therapy 52

Therapy Pharmaceutical Clinical Trials Access 52

The Joint Blog

OCTOBER 21, 2020

Due to the updated hemp act being relatively new, lawmakers are still studying and formulating policies that can better improve the industry while regulating it for the safety of users. Although scientific research on this has a long way to go, previous studies and clinical trials have produced promising results.

CBD 36

CBD Legalization Oil Hemp 36

NORML

JANUARY 18, 2019

House lawmakers introduced The Medical Cannabis Research Act of 2019 (HR 601), to facilitate federally-approved clinical trials involving cannabis. Legislation is pending, House Bill 625, to establish an industrial hemp pilot program to be in compliance with the new federal hemp regulations. Mississippi. MS resident? Washington.

Legislation 165

Legislation Decriminalization Access Therapy 165

Cannabis Law Report

JUNE 1, 2021

Drake received her bachelor’s degree from Wichita State University and is a graduate of the Harvard Business School Executive Leadership Program. In prior clinical trials conducted by Sesen Bio, EpCAM has been shown to be overexpressed in NMIBC cells with minimal to no EpCAM expression observed on normal bladder cells.

Research and Development 66

Research and Development Treatment Pharmaceutical Patients 66

Cannabis Law Report

JULY 25, 2022

Reporter Elise Worthington also investigates the dark side of this form of therapy where disturbing cases of abuse and malpractice are emerging in both clinical trials and the underground. She was a Harkness Fellow in Health Care Policy, a VicHealth Fellow in Health Promotion and an NHMRC Fellow in Suicide Prevention.

Medicine 52

Medicine Therapy Research and Development Business 52

The Cannigma

JUNE 15, 2021

Families looking for the wonder plant started migrating to states with medical cannabis programs , becoming cannabis refugees, and their stories spread even further. . Sonya Yruel/Drug Policy Alliance). In contrast, many hemp-derived CBD products are not subject to the rigorous standards in place for most medical marijuana programs.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

AUGUST 25, 2022

The MAPS Policy and Advocacy team coordinated a bipartisan coalition that met with U.S. Policy and Advocacy Director, MAPS. Its main focuses include establishing sentencing policies, advising Congress and the executive branch in developing criminal justice policy, and analyzing and distributing information on federal sentencing issues.

Research and Development 52

Research and Development Advocacy Clinical Trials Policy 52

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. The MDMA Therapy Training Program was created to train the next generation of psychedelic therapists. Rick Doblin, Ph.D.,

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

MAY 1, 2022

The Psychedelic Bar Association (PBA) is an association of attorneys and legal professionals dedicated to solving the novel legal and policy issues impacting the emerging psychedelics sector. The PBA Religious Use Committee provides expertise around the intersections of law, policy, psychedelics, and religion.

Safety 52

Safety History Programs Clinical Trials 52

Cannabis Law Report

AUGUST 30, 2019

The National Institute on Drug Abuse published a grant notice to encourage research on the effects of changing US cannabis laws and policies on public health. The city council unanimously approved a resolution allowing consumers at The Fairbanks Cut to consume cannabis on-site as part of the state’s recreational cannabis program.

Banking 45

Banking Research and Development Legislation Programs 45

Canna Law Blog

MAY 7, 2020

This was before implementation of the federal government’s Compassionate Investigational New Drug Program (CINDP), which Ole Miss’s grow now serves in addition to its research. for various studies, including FDA-approved clinical trials. These cannabis products are used by researchers in the U.S.

DEA 72

DEA Research and Development Cultivation Supply Chain 72

Project CBD

NOVEMBER 11, 2023

And many of them were thinking of dropping out of medicine altogether because the practice of it has become so unsatisfactory until they discovered this program and it renewed their reasons for why they went into medicine in the first place. NM: Do you teach nurses as well? So that’s a different training. And we also train residents.

Medicine 301

Medicine Research and Development Pharmaceutical Cannabis 301

The Cannigma

MAY 7, 2021

Europe’s obviously come a long way and most of the countries on the continent have varying degrees of medical programs alongside going hemp industries but can you start by giving a quick overview of where Europe is in comparison to North America but also your thoughts on why the momentum seems to be different? MSO: Let’s pivot for a minute.

Supply Chain 120

Supply Chain Patients Access Hemp 120

The Cannigma

MARCH 12, 2021

We’re not going to get over the fact that there’s not the same sort of clinical trial and that type of evidence for cannabis and cannabis treatments in the very near future for various reasons. But what happens to the medical programs and access and probably in ways that I don’t even know what to ask?

Legalization 128

Legalization Patients Education Dispensary 128

Cannabis Law Report

OCTOBER 20, 2021

The CBD brand FullSend claims Nelk has conducted an “enforcement program” to put it out of business by threatening it with litigation and demanding it stop selling and advertising its products under what FullSend claims is its own mark. Critics of the policies point to the U.S. to interfere with its business. Thomas, which said Tenn.

Hemp 52

Hemp Clinical Trials CBD Legalization 52

Weedistry

FEBRUARY 4, 2019

One of the most common arguments against the efficacy of medical cannabis today is that public policy is outpacing real science. Just because we don’t yet have clinical trial results that confirm medical cannabis relieves pain, or eases insomnia, or reduces inflammation, etc., doesn’t mean it doesn’t work.

Clinical Trials 40

Clinical Trials Pharmaceutical Chronic Pain Safety 40

Cannabis Law Report

AUGUST 7, 2022

In recent years, as more clinical trial results show that psychedelics can be used in conjunction with therapy to treat illnesses like depression and post-traumatic stress disorder, legislators pushed to make certain substances available in certain settings. Psychedelic Alpha Policy Map.

Law 74

Law Research and Development Therapy Treatment 74

Cannabis Law Report

JUNE 4, 2021

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Amanda Feilding, Countess of Wemyss and March is an English drug policy reformer, lobbyist and research coordinator. Andrew Yang.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

Cannabis Law Report

JULY 21, 2022

“With strong restorative justice provisions for communities impacted by the drug war, support for small cannabis businesses, and expungement of federal cannabis offenses, this bill reflects long overdue, common sense drug policy. Cannabis legalization is here, and Congress needs to get with the program.”

Safety 52

Safety Legislation Clinical Trials Banking 52

SpeedWeed

DECEMBER 28, 2018

The facility, which has a “zero tolerance” policy on “drug use” (except alcohol and pharmaceuticals) kicked Flickner to the curb in the freezing cold despite the fact that he uses a wheelchair and has a doctor’s recommendation to consume medical cannabis per state law.

Pharmaceutical 40

Pharmaceutical Research and Development Legalization CBD 40

Cannabis Law Report

OCTOBER 17, 2019

For non-US citizens, Malyshev explains, this can result in a lifetime ban from entry into the US under current policy. The FDA has started to hold hearings to determine whether it will change its policy on foods and beverages containing CBD made from industrial hemp, and CBD products more broadly.

Law 40

Law Seed-To-Sale Hemp Recreational 40

Veriheal

JULY 18, 2023

The Grant Program Details The heart of this landmark legislation lies in the development of a robust grant program. Notably, the grant program will target three prevalent and often debilitating conditions in military personnel: PTSD, traumatic brain injury (TBI) , and chronic traumatic encephalopathy (CTE).

Treatment 98

Treatment Clinical Trials Research and Development Legislation 98

NORML

JANUARY 28, 2019

Presidents Barack Obama and Donald Trump have voiced support for state governments deciding their own policies. The National Center for Biotechnology Information has summarized a group of FDA approved randomized clinical trials, finding evidence for cannabis as medicine. So, in seven years why hasn’t Kentucky moved forward?

Data 189

Data Clinical Trials Chronic Pain Medicine 189

Cannabis Law Report

JUNE 30, 2019

New Mexico expands medical cannabis program to include protections against discrimination, reciprocity with other states’ medical programs, and three-year renewal cycle (up from one) for medial cannabis cards; and. The Federal Aviation Administration issued a bulletin clarifying its cannabis and CBD policy for pilots.

Chronic Pain 40

Chronic Pain Legislation Treatment Programs 40

Cannabis Law Report

DECEMBER 30, 2019

Illinois and the US territory of Guam legalized adult-use cannabis and its retail sale, medical cannabis programs were enacted and expanded in several states, and 27 states considered legislation that would have legalized adult-use cannabis, a record-high. Historic House Judiciary Hearing on Marijuana Policy. Erik Altieri.

Legislation 59

Legislation Patients Access Banking 59